Olivier Lieven
Partner, Healthcare Flagship
In Portfolio
Oxoid Remel Microbiology
The company is an independent global microbiology diagnostics specialist, created in August 2026 through the carve-out of the Microbiology business of Thermo Fisher Scientific. Led by CEO Dirk Bontridder, the company will launch under a new corporate brand later in 2026.
Overview
TFM (Clémentine) provides diagnostic consumables and equipment used in microbiological testing across clinical, food safety and pharmaceutical applications.
Head Office
Bruxelles
Global Sales
The company serves more than 15,000 customers across over 100 countries, through a direct sales force and its network of distributors.
Headcount:
c.2,400 employees
Geographical sales:
US c.40%, Europe c. 40%, Rest of world: c.20%
$650Mas of 2025
Healthcare sector2026 Entry into PortfolioFund Astorg VIIIHealthcare sector2026 Entry into PortfolioFund Astorg VIIIHealthcare sector2026 Entry into PortfolioFund Astorg VIIIHealthcare sector2026 Entry into PortfolioFund Astorg VIIIHealthcare sector2026 Entry into PortfolioFund Astorg VIII
Meet the team behind our deep
expertise and market-leading results
Paul Arhanchiague
Managing Director, Healthcare Flagship
Fayçal Battou
Associate
